- Home
- MFIN vs HRTX Comparison
MFIN vs HRTX Comparison
Compare MFIN & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.18
Company Overview
Basic Information| Metric | MFIN | HRTX |
|---|---|---|
| Founded | 1995 | 1983 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.7M | 265.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MFIN | HRTX |
|---|---|---|
| Price | $10.35 | $1.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $4.50 |
| AVG Volume (30 Days) | 42.2K | ★ 1.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | $5.83 | $11.61 |
| P/E Ratio | $6.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.71 | $1.00 |
| 52 Week High | $10.98 | $2.68 |
Technical Indicators
Market Signals| Indicator | MFIN | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.86 | 39.33 |
| Support Level | $10.23 | $1.11 |
| Resistance Level | $10.60 | $1.30 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 76.92 | 25.81 |
Price Performance
Historical Comparison MFIN
HRTX
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.